The Ensign Group (ENSG)
(Delayed Data from NSDQ)
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Zacks News
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Ensign Group (ENSG) Rises 30% in 6 Months: More Room to Run?
by Zacks Equity Research
Ensign Group (ENSG) is well-poised for improvement on growing revenues derived from catering to patients under Medicaid and Medicare programs. Solid cash flows are other tailwinds.
4 Stocks to Watch on Dividend Hikes Before 2022 Comes to a Close
by Ritujay Ghosh
Sandstorm Gold Ltd. (SAND), The Mosaic Company (MOS), The Ensign Group, Inc. (ENSG) and Preferred Bank (PFBC) recently hiked dividends.
Acadia Healthcare (ACHC) Up 42% in a Year: More Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) is well-poised for growth on a diversified healthcare treatment network resulting from growth-related efforts.
Ensign Group (ENSG) Unveils Dividend Hike to Reward Shareholders
by Zacks Equity Research
Ensign Group's (ENSG) latest dividend hike reflects strong financial standing and intensified focus in the tactical deployment of capital.
Ensign Group (ENSG) Facility Buyout to Boost Colorado Foothold
by Zacks Equity Research
Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado that are likely to grow its healthcare portfolio and solidify its nationwide presence.
Ensign Group (ENSG) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Ensign Group (ENSG) Shares Up 2% Despite Q3 Earnings Miss
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter results reflect strength in the Skilled Services segment. A hiked 2022 EPS guidance remains noteworthy. However, escalated expenses are bothersome.
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Medpace (MEDP) and Ensign Group (ENSG) have performed compared to their sector so far this year.
Ensign Group (ENSG) Q3 Earnings Lag Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of -0.95% and 2.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Ensign Group (ENSG) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit
by Zacks Equity Research
Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.
Why Should You Add Ensign Group (ENSG) to Portfolio Now?
by Zacks Equity Research
Ensign Group (ENSG) benefits from a growing healthcare portfolio as a result of multiple facility buyouts. Solid cash-generating abilities empower ENSG to invest in growth-related initiatives.
Humana (HUM) Brings Home Health Unit of KAH Under CenterWell
by Zacks Equity Research
Humana (HUM) wraps up rebranding KAH's home health operations to the CenterWell brand. This leads to the clubbing of HUM's three payer-agnostic care services into a common suite.
Ensign Group (ENSG) Down 2.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna (CI) to Widen Access to Individual Health Plans in 2023
by Zacks Equity Research
Cigna (CI) unveils enhanced individual and family health plans for its customers to opt for in the 2023 Open Enrollment Period. CI will enter newer counties and states to offer better health outcomes.
Teladoc Health (TDOC) Ties Up to Upgrade RPM Care in Canada
by Zacks Equity Research
Teladoc Health (TDOC) teams up with Cloud DX to bring its virtual care capabilities to the latter's platform and dispense advanced RPM solutions to the Canadian residents.
Has BioCardia (BCDA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how BioCardia, Inc. (BCDA) and Ensign Group (ENSG) have performed compared to their sector so far this year.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Here is Why Growth Investors Should Buy Ensign Group (ENSG) Now
by Zacks Equity Research
Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.
Ensign Group (ENSG) Meets Q2 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 0.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) on a Buyout Binge to Boost US Footprint
by Zacks Equity Research
Ensign Group (ENSG) executes a slew of buyouts to offer better healthcare services to the U.S. residents and further penetrate its operational markets.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH